Trial reportBMJ open2014
A Community Jury on PSA screening: what do well-informed men want the government to do about prostate cancer screening--a qualitative analysis.
Trial report in BMJ open, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 37 citations in OpenAlex.
- Trial
- Should women aged 70-74 be invited to participate in screening mammography? A report on two Australian community juries.BMJ open · 2018Trial
- Trial
- Public Engagement in Health Policy-Making for Older Adults: A Systematic Search and Scoping Review.Health expectations : an international journal of public participation in health care and health policy · 2024Article
- Article
- A community jury study exploring the public acceptability of using risk stratification to determine eligibility for cancer screening.Health expectations : an international journal of public participation in health care and health policy · 2022Article
- PROSHADE Protocol: Designing and Evaluating a Decision Aid for Promoting Shared Decision Making in Opportunistic Screening for Prostate Cancer: A Mix-Method Study.International journal of environmental research and public health · 2022Article
- Delivering the unexpected-Information needs for PSA screening from Men's perspective: A qualitative study.Health expectations : an international journal of public participation in health care and health policy · 2021Article
- Article
- Resisting recommended treatment for prostate cancer: a qualitative analysis of the lived experience of possible overdiagnosis.BMJ open · 2019Article
- Deciding on cystic fibrosis carrier screening: three citizens' juries and an online survey.European journal of public health · 2018Article
- Valuing Healthcare Improvement: Implicit Norms, Explicit Normativity, and Human Agency.Health care analysis : HCA : journal of health philosophy and policy · 2018Article
- CJCheck Stage 1: development and testing of a checklist for reporting community juries - Delphi process and analysis of studies published in 1996-2015.Health expectations : an international journal of public participation in health care and health policy · 2017Article
- Article
- Mode of prostate cancer detection is associated with the psychological wellbeing of survivors: results from the PiCTure study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016Article
- Article
- Cystic fibrosis: to screen or not to screen? Involving a Citizens' jury in decisions on screening carrier.Health expectations : an international journal of public participation in health care and health policy · 2015Article
- The role of communication in breast cancer screening: a qualitative study with Australian experts.BMC cancer · 2015Article
- Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study.BMJ open · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCancer screening policies and programmes should take account of public values and concerns. This study sought to determine the priorities, values and concerns of men who were 'fully informed' about the benefits and harms of prostate-specific antigen (PSA) screening; and empirically examine the value of a community jury in eliciting public values on PSA screening.
settingCommunity jury was convened on the Gold Coast, Queensland (Australia) to consider PSA screening benefits and harms, and whether government campaigns on PSA screening should be conducted.
participants27 men (volunteers) aged 50-70 with no personal history of prostate cancer and willing to attend jury 6-7 April 2013: 12 were randomly allocated to jury (11 attended). OUTCOME MEASURES: A qualitative analysis was conducted of the jury deliberations (audio-recorded and transcribed) to elicit the jury's views and recommendations. A survey determined the impact of the jury process on participants' individual testing decisions compared with control group.
resultsThe jury concluded governments should not invest in programmes focused on PSA screening directed at the public because the PSA test did not offer sufficient reassurance or benefit and could raise unnecessary alarm. It recommended an alternative programme to support general practitioners to provide patients with better quality and more consistent information about PSA screening. After the jury, participants were less likely to be tested in the future compared with the controls, but around half said they would still consider doing so.
conclusionsThe jury's unanimous verdict about government programmes was notable in the light of their divergent views on whether or not they would be screened themselves in the future. Community juries provide valuable insights into the priorities and concerns of men weighing up the benefits and harms of PSA screening. It will be important to assess the degree to which the findings are generalisable to other settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.